Chinese Government Venture Firm Funds JV To Explore Early-stage Oncology Trials
This article was originally published in The Pink Sheet Daily
Executive Summary
U.S. South Texas Accelerated Research Therapeutics will partner with Shanghai-based Cenova Ventures to conduct early-stage oncology trials for pharma companies on both sides of the Pacific.
You may also be interested in...
Hutchison Medipharma Initiates Phase I Trials Of Cancer-fighting Candidate Sulfatinib In China
SHANGHAI - Chinese innovative drug developer Hutchison MediPharma has initiated Phase I clinical trials in China for its anti-cancer drug candidate, HMPL-012 (sulfatinib), the company said May 6
GSK Jumps Into Growing China R&D Space
GlaxoSmithKline has joined a growing list of big pharma companies expanding in China, launching a research and development center based in Shanghai, the company announced May 24
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.